Identification and validation of serum SLIT1 as a biomarker for predicting anti-PD-1/PD-L1 resistance in non-small cell lung cancer
{{output}}
Background: Non-small cell lung cancer (NSCLC), the predominant subtype of lung cancer, contributes greatly to cancer-related mortality worldwide. Although inhibitors of programmed cell death protein 1 (PD-1) and its ligand PD-L1... ...
